Literature DB >> 8062488

Propranolol metabolism in normal subjects: association with sex steroid hormones.

T Walle1, K Walle, R S Mathur, Y Y Palesch, E C Conradi.   

Abstract

The objective of this study was to determine the potential role of circulating testosterone and estradiol in regulation of the activity of the sex-dependent pathways of propranolol metabolism (i.e., alpha-naphthoxylactic acid and propranolol glucuronide). The pharmacokinetics of a single 80 mg oral dose of propranolol and the plasma levels of the sex steroid hormones were therefore determined in normal volunteers. In 33 young men there was a positive correlation between the testosterone levels and the propranolol clearances through both alpha-naphthoxylactic acid (p < 0.001) and propranolol glucuronide (p < 0.002), as well as the total clearance (p < 0.05), but not through aromatic ring hydroxylation. Testosterone cypionate administration led to an increased clearance of propranolol through alpha-naphthoxylactic acid in nine of the 11 men studied, further supporting a stimulatory effect of testosterone on propranolol metabolism. In 23 young women there was no significant association between the circulating levels of either estradiol or testosterone and any of the clearances of propranolol. These observations may be clinically relevant for propranolol therapy and may provide improved insight into the influence of gender and circulating gonadal hormones on drug metabolism in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062488     DOI: 10.1038/clpt.1994.115

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  The role of non-P450 enzymes in drug oxidation.

Authors:  C Beedham
Journal:  Pharm World Sci       Date:  1997-12

Review 2.  Gender aspects in cardiovascular pharmacology.

Authors:  Sabine Oertelt-Prigione; Vera Regitz-Zagrosek
Journal:  J Cardiovasc Transl Res       Date:  2009-06-12       Impact factor: 4.132

Review 3.  Atrial fibrillation in women: treatment.

Authors:  Darae Ko; Faisal Rahman; Maria A P Martins; Elaine M Hylek; Patrick T Ellinor; Renate B Schnabel; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-10-27       Impact factor: 32.419

Review 4.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 5.  [Sex differences in cardiovascular drug targeting].

Authors:  V Regitz-Zagrosek; C Schubert; S Krüger
Journal:  Internist (Berl)       Date:  2008-11       Impact factor: 0.743

6.  Sex- and Gender-Based Pharmacological Response to Drugs.

Authors:  Franck Mauvais-Jarvis; Heiner K Berthold; Ilaria Campesi; Juan-Jesus Carrero; Santosh Dakal; Flavia Franconi; Ioanna Gouni-Berthold; Mark L Heiman; Alexandra Kautzky-Willer; Sabra L Klein; Anne Murphy; Vera Regitz-Zagrosek; Karen Reue; Joshua B Rubin
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  Does reconsolidation occur in humans?

Authors:  Daniela Schiller; Elizabeth A Phelps
Journal:  Front Behav Neurosci       Date:  2011-05-17       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.